Synthesis and Evaluation of D8W, an Octadentate Desferrioxamine Analogue with Enhanced Water Solubility Designed for 89 Zr-ImmunoPET Imaging
Molecular Pharmaceutics · 2026
DOI: 10.1021/acs.molpharmaceut.5c01947 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2026. Verfasst von James L Wood und 8 weiteren Autor:innen. Beteiligte Einrichtung: Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, Queensland 4072, Australia. Hauptthemen laut MEDLINE: Zirconium, Deferoxamine, Radioisotopes, Positron-Emission Tomography. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: University of Sydney, Australian Research Council.
Abstract (Originalsprache)
Antibody-based zirconium-89 (89Zr)-containing immunological positron emission tomography (immuno-PET) agents have applications in high-precision cancer imaging. These agents require a bifunctional chelator to bind the positron-emitting 89Zr isotope and facilitate the covalent attachment to a cancer-targeting monoclonal antibody (mAb). The hexadentate hydroxamic acid chelator desferrioxamine B (DFO) is commonly used in the development of 89Zr-immunoPET agents. While DFO is efficiently radiolabeled with 89Zr, vacancies in the unsaturated 89Zr-DFO coordination sphere can reduce the 89Zr-DFO complex stability and increase the risk of 89Zr dissociating and accumulating in nontarget tissues, particularly bone. This potential shortcoming of 89Zr-DFO can be addressed by using an octadentate chelator to fully saturate the 89Zr coordination sphere. The octadentate chain-extended DFO analogue DFO* was the first exemplar of this class and showed 89Zr-DFO* was more stable than 89Zr-DFO. The current work designed, synthesized, and evaluated the properties of a new octadentate DFO analogue, named D8W, where "W" designates "water-soluble". This property has been built into D8W by including water-solubilizing ether oxygen atoms in the hydroxamic acid extension unit appended to DFO and a PEG4 unit. Comparison of the two most water-soluble chelators from the set of DFO, DFO* and D8W, showed that compared to [89Zr]Zr-DFO-mAb (mAb = Girentuximab), [89Zr]Zr-D8W-mAb had improved 89Zr radiolabeling kinetics and in vitro stability. Key to its utility, bone deposition of 89Zr was lower for [89Zr]Zr-D8W-mAb than [89Zr]Zr-DFO-mAb, as assessed by PET imaging in a CAIX-expressing HT-29 tumor-bearing Balb/C nude mouse model. The performance of D8W coupled with its water solubility supports its merit in its use in 89Zr-immunoPET agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Australian Institute for Bioengineering and Nanotechnology (AIBN), The University of Queensland, Brisbane, Queensland 4072, Australia.
- School of Medical Sciences, The University of Sydney, Sydney, New South Wales 2006, Australia.
- ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals, The University of Queensland, Brisbane, Queensland 4067, Australia.
- Telix Pharmaceuticals Limited, North Melbourne, Victoria 3051, Australia.
ORCID-Profile: James L Wood, Callum A Rosser, Christopher J M Brown, Nicholas L Fletcher, Kristofer J Thurecht, Rachel Codd
Förderung
- University of Sydney
- Australian Research Council
Zitieren
APA
Wood, J. L., Ghosh, S., Rosser, C. A., Feeney, S. V., Brown, C. J. M., Fletcher, N. L., Wheatcroft, M. P., Thurecht, K. J., & Codd, R. (2026). Synthesis and Evaluation of D8W, an Octadentate Desferrioxamine Analogue with Enhanced Water Solubility Designed for 89 Zr-ImmunoPET Imaging. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.5c01947
Vancouver
Wood JL, Ghosh S, Rosser CA, Feeney SV, Brown CJM, Fletcher NL, et al. Synthesis and Evaluation of D8W, an Octadentate Desferrioxamine Analogue with Enhanced Water Solubility Designed for 89 Zr-ImmunoPET Imaging. Molecular Pharmaceutics. 2026. doi:10.1021/acs.molpharmaceut.5c01947
BibTeX
@article{Wood2026,
author = {Wood, James L and Ghosh, Saikat and Rosser, Callum A and Feeney, Samuel V and Brown, Christopher J M and Fletcher, Nicholas L and Wheatcroft, Michael P and Thurecht, Kristofer J and Codd, Rachel},
title = {Synthesis and Evaluation of D8W, an Octadentate Desferrioxamine Analogue with Enhanced Water Solubility Designed for 89 Zr-ImmunoPET Imaging},
journal = {Molecular Pharmaceutics},
year = {2026},
doi = {10.1021/acs.molpharmaceut.5c01947}
}
EUVIMED